Physical characteristics of novel nanomagnetic radiopharmaceuticals: a review

Authors

  • Noor Hadi Aysa
  • Safa Wahab Aziz
  • Rasha Hadi Saleh
  • Lena Fadhil Hamza
  • Rafal Al-Assaly

DOI:

https://doi.org/10.60988/p.v37i2S.274

Keywords:

nanomagnetic radiopharmaceuticals; drugs; cancer; nuclear medicine; nanoparticles

Abstract

Hybrid nanomagnetic radiopharmaceuticals represent a frontier in targeted therapy and diagnostic imaging. These compounds synergistically combine magnetic nanoparticles with radiopharmaceutical agents in order to enhance the precision, delivery, and therapeutic efficacy of nuclear medicine interventions. This review summarizes their physicochemical properties, presents their mechanisms of action, and discusses their translational potential across a range of clinical applications.

Author Biographies

Noor Hadi Aysa

College of Pharmacy, University of Babylon, Hillah, Iraq

Safa Wahab Aziz

College of Pharmacy, University of Babylon, Hillah, Iraq

Rasha Hadi Saleh

College of Pharmacy, University of Babylon, Hillah, Iraq

Lena Fadhil Hamza

College of Pharmacy, University of Babylon, Hillah, Iraq

Rafal Al-Assaly

College of Pharmacy, University of Babylon, Hillah, Iraq

References

1. Sung B., Kim M.H., Abelmann L. Magnetic microgels and nanogels: physical mechanisms and biomedical applications. Bioeng. Transl. Med. 6(1), e10190, 2020. DOI: 10.1002/btm2.10190

2. Siafaka P.I., Okur N.Ü., Karantas I.D., Okur M.E., Gündoğdu E.A. Current update on nanoplatforms as therapeutic and diagnostic tools: a review for the materials used as nanotheranostics and imaging modalities. Asian J. Pharm. Sci. 16(1), 24–46, 2021. DOI: 10.1016/j.ajps.2020.03.003

3. Katz E. Synthesis, properties and applications of magnetic nanoparticles and nanowires -- a brief introduction. Magnetochemistry 5(4), 61, 2019. DOI: 10.3390/magnetochemistry5040061

4. Salih S., Elliyanti A., Alkatheeri A., AlYafei F., Almarri B., Khan H. The role of molecular imaging in personalized medicine. J. Pers. Med. 13(2), 369, 2023. DOI: 10.3390/jpm13020369

5. Senapati S., Mahanta A.K., Kumar S., Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct. Target. Ther. 3, 7, 2018. DOI: 10.1038/s41392-017-0004-3

6. Calatayud D.G., Neophytou S., Nicodemou E., Giuffrida S.G., Ge H., Pascu S.I. Nano-theranostics for the sensing, imaging and therapy of prostate cancers. Front. Chem. 10, 830133, 2022. DOI: 10.3389/fchem.2022.830133

7. Kaewput C., Vinjamuri S. Update of PSMA theranostics in prostate cancer: current applications and future trends. J. Clin. Med. 11(10), 2738, 2022. DOI: 10.3390/jcm11102738

8. Mues B., Bauer B., Roeth A.A., Ortega J., Buhl E.M., Radon P., et al. Nanomagnetic actuation of hybrid stents for hyperthermia treatment of hollow organ tumors. Nanomaterials (Basel) 11(3), 618, 2021. DOI: 10.3390/nano11030618

9. Yao Y., Zhou Y., Liu L., Xu Y., Chen Q., Wang Y., et al. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front. Mol. Biosci. 7, 193, 2020. DOI: 10.3389/fmolb.2020.00193

10. Sadiq S., Khan I., Shen Z., Wang M., Xu T., Khan S., et al. Recent updates on multifunctional nanomaterials as antipathogens in humans and livestock: classification, application, mode of action, and challenges. Molecules 28(22), 7674, 2023. DOI: 10.3390/molecules28227674

Downloads

Published

10-10-2025

How to Cite

[1]
Aysa, N.H. et al. 2025. Physical characteristics of novel nanomagnetic radiopharmaceuticals: a review. Pharmakeftiki . 37, 2S (Oct. 2025). DOI:https://doi.org/10.60988/p.v37i2S.274.

Issue

Vol. 37 No. 2S (2025): Pharmakeftiki Special issue

Section

Review